Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Frontiers in Surgery
|
October 17, 2022
Single-site multiport vs. conventional multiport robot-assisted radical prostatectomy: A propensity score matching comparative study
Weibin Hou, Bingzhi Wang, Lei Zhou, et al.
Cancer Immunology, Immunotherapy : CII
|
February 19, 2021
Development and validation of a PD-L1/PD-1/CD8 axis-based classifier to predict cancer survival of upper tract urothelial carcinoma after radical nephroureterectomy
Junyu Chen, Wenlong Zhong, Meng Yang, et al.
Cancer Drug Resistance (Alhambra, Calif.)
|
August 22, 2025
Integrated multi-omics profiling of immune microenvironment and drug resistance signatures for precision prognosis in prostate cancer
Chao Li, Longxiang Wu, Bowen Zhong, et al.
Materials Today. Bio
|
March 27, 2023
Recent advances in aptamer-based therapeutic strategies for targeting cancer stem cells
Biao Liu, Jiahao Liu, Xing Hu, et al.
Oncoimmunology
|
September 14, 2020
Serum CCL27 predicts the response to Bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer
Wenlong Zhong, Bo Wang, Hao Yu, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 29, 2026
Comparison of PET imaging of [18F]F-FAPI and [18F]F-FDG for diagnosis of suspected lymph node metastases in penile squamous cell carcinoma: a prospective pilot study
Wei Ouyang, Xiaopeng Tong, Weibin Hou, et al.
Frontiers in Immunology
|
April 7, 2022
Negative Effects of Stromal Neutrophils on T Cells Reduce Survival in Resectable Urothelial Carcinoma of the Bladder
Meihua Yang, Bo Wang, Weibin Hou, et al.
Biomedicines
|
June 2, 2021
Targeting the Proteasome in Advanced Renal Cell Carcinoma: Complexity and Limitations of Patient-Individualized Preclinical Drug Discovery
Jielin Li, Laura Pohl, Julia Schüler, et al.
Biomaterials Science
|
January 21, 2025
A novel therapeutic strategy utilizing EpCAM aptamer-conjugated gemcitabine for targeting bladder cancer and cancer stem cells
Jiahao Liu, Long Wang, Yongbo Peng, et al.
Journal for Immunotherapy of Cancer
|
July 27, 2024
NAD<sup>+</sup> metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer
Meihua Yang, Bo Wang, Weibin Hou, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Frontiers in Surgery
|
October 17, 2022
Single-site multiport vs. conventional multiport robot-assisted radical prostatectomy: A propensity score matching comparative study
Weibin Hou, Bingzhi Wang, Lei Zhou, et al.
Cancer Immunology, Immunotherapy : CII
|
February 19, 2021
Development and validation of a PD-L1/PD-1/CD8 axis-based classifier to predict cancer survival of upper tract urothelial carcinoma after radical nephroureterectomy
Junyu Chen, Wenlong Zhong, Meng Yang, et al.
Cancer Drug Resistance (Alhambra, Calif.)
|
August 22, 2025
Integrated multi-omics profiling of immune microenvironment and drug resistance signatures for precision prognosis in prostate cancer
Chao Li, Longxiang Wu, Bowen Zhong, et al.
Materials Today. Bio
|
March 27, 2023
Recent advances in aptamer-based therapeutic strategies for targeting cancer stem cells
Biao Liu, Jiahao Liu, Xing Hu, et al.
Oncoimmunology
|
September 14, 2020
Serum CCL27 predicts the response to Bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer
Wenlong Zhong, Bo Wang, Hao Yu, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 29, 2026
Comparison of PET imaging of [18F]F-FAPI and [18F]F-FDG for diagnosis of suspected lymph node metastases in penile squamous cell carcinoma: a prospective pilot study
Wei Ouyang, Xiaopeng Tong, Weibin Hou, et al.
Frontiers in Immunology
|
April 7, 2022
Negative Effects of Stromal Neutrophils on T Cells Reduce Survival in Resectable Urothelial Carcinoma of the Bladder
Meihua Yang, Bo Wang, Weibin Hou, et al.
Biomedicines
|
June 2, 2021
Targeting the Proteasome in Advanced Renal Cell Carcinoma: Complexity and Limitations of Patient-Individualized Preclinical Drug Discovery
Jielin Li, Laura Pohl, Julia Schüler, et al.
Biomaterials Science
|
January 21, 2025
A novel therapeutic strategy utilizing EpCAM aptamer-conjugated gemcitabine for targeting bladder cancer and cancer stem cells
Jiahao Liu, Long Wang, Yongbo Peng, et al.
Journal for Immunotherapy of Cancer
|
July 27, 2024
NAD<sup>+</sup> metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer
Meihua Yang, Bo Wang, Weibin Hou, et al.
Page
of 4